SCHEMBL528759

SCHEMBL528759

COC(=O)c1cc(F)cc2c(Cl)ncnc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
CSNK2A1 P68400 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
TP53 P04637 1/20 0.37
RPS6KB1 P23443 3/20 0.36
AURKA O14965 3/20 0.36
ATR Q13535 1/20 0.36
PLA2G2A P14555 3/20 0.36
PDPK1 O15530 1/20 0.36
PSMD14 O00487 1/20 0.35
ABL1 P00519 1/20 0.35
AURKB Q96GD4 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
NR4A2 P43354 2/20 0.34
NQO2 P16083 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL666532 0.85 TP53 (0.46) KDM4ECSNK2A1ALDH1A1TP53ATR
SCHEMBL1462290 0.84 CSNK2A1 (0.39) KDM4ECSNK2A1ALDH1A1MAPTTP53
SCHEMBL666811 0.83 CSNK2A1 (0.38) KDM4ECSNK2A1ALDH1A1MAPTTP53
SCHEMBL667220 0.83 RPS6KB1 (0.47) KDM4EALDH1A1RPS6KB1AURKAPLA2G2A
SCHEMBL31721702 0.83 CSNK2A1 (0.38) KDM4ECSNK2A1ALDH1A1MAPTTP53
SCHEMBL1463050 0.82 ALDH1A1 (0.40) KDM4EALDH1A1MAPTMAPK1RPS6KB1
SCHEMBL527746 0.77 PSMD14 (0.46) KDM4EALDH1A1MAPTRPS6KB1AURKA
SCHEMBL24392592 0.75 ALDH1A1 (0.48) KDM4EALDH1A1MAPTMAPK1AURKA
SCHEMBL31721750 0.74 CYP1A2 (0.44) KDM4EALDH1A1MAPK1
SCHEMBL666921 0.74 AURKA (0.51) KDM4EALDH1A1RPS6KB1AURKAPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10087166-B2 Cyclic amine azaheterocyclic carboxamides MERCK PATENT GMBH (DE) 2018-10-02 US disclosed
US-20170129877-A1 Cyclic Amine Azaheterocyclic Carboxamides MERCK PATENT GMBH (DE) 2017-05-11 US disclosed
US-9586938-B2 Cyclic amine azaheterocyclic carboxamides MERCK PATENT GMBH (DE) 2017-03-07 US disclosed
US-20130217709-A1 Cyclic Amine Azaheterocyclic Carboxamides MERCK PATENT GMBH (DE) 2013-08-22 US disclosed
EP-2598497-A1 CYCLIC AMINE AZAHETEROCYCLIC CARBOXAMIDES Merck Patent GmbH (DE) 2013-06-05 EP disclosed
WO-2012016001-A1 CYCLIC AMINE AZAHETEROCYCLIC CARBOXAMIDES MERCK PATENT GMBH (DE) 2012-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217709-A1 Cyclic Amine Azaheterocyclic Carboxamides MKI67, AZI2, PCNA KDM4E 507/4885CSNK2A1 707/4885ALDH1A1 673/4885
US-20170129877-A1 Cyclic Amine Azaheterocyclic Carboxamides MKI67, AZI2, PCNA KDM4E 507/4885CSNK2A1 707/4885ALDH1A1 673/4885
US-10087166-B2 Cyclic amine azaheterocyclic carboxamides MKI67, AZI2, PCNA KDM4E 507/4885CSNK2A1 707/4885ALDH1A1 673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.